Cargando…
The Heparan Sulfate Mimetic PG545 Modulates T Cell Responses and Prevents Delayed-Type Hypersensitivity
The heparan sulfate mimetic PG545 (pixatimod) is under evaluation as an inhibitor of angiogenesis and metastasis including in human clinical trials. We have examined the effects of PG545 on lymphocyte phenotypes and function. We report that PG545 treatment suppresses effector T cell activation and p...
Autores principales: | Koliesnik, Ievgen O., Kuipers, Hedwich F., Medina, Carlos O., Zihsler, Svenja, Liu, Dan, Van Belleghem, Jonas D., Bollyky, Paul L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7015948/ https://www.ncbi.nlm.nih.gov/pubmed/32117279 http://dx.doi.org/10.3389/fimmu.2020.00132 |
Ejemplares similares
-
Mechanisms of heparanase inhibition by the heparan sulfate mimetic PG545 and three structural analogues()
por: Hammond, Edward, et al.
Publicado: (2013) -
The heparan sulfate mimetic PG545 interferes with Wnt/β-catenin signaling and significantly suppresses pancreatic tumorigenesis alone and in combination with gemcitabine
por: Jung, Deok-Beom, et al.
Publicado: (2014) -
Correction: The heparan sulfate mimetic PG545 interferes with Wnt/β-catenin signaling and significantly suppresses pancreatic tumorigenesis alone and in combination with gemcitabine
por: Jung, Deok-Beom, et al.
Publicado: (2019) -
Synthetic Heparan Sulfate Mimetic Pixatimod (PG545)
Potently Inhibits SARS-CoV-2 by Disrupting the Spike–ACE2
Interaction
por: Guimond, Scott E., et al.
Publicado: (2022) -
PG545, a Heparan Sulfate Mimetic, Reduces Heparanase Expression In Vivo, Blocks Spontaneous Metastases and Enhances Overall Survival in the 4T1 Breast Carcinoma Model
por: Hammond, Edward, et al.
Publicado: (2012)